Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 4, 2007 - Issue 2
Submit an article Journal homepage
130
Views
18
CrossRef citations to date
0
Altmetric
Review

Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson’s disease

Y Naidu Research Nurse and Co-ordinator, University Hospital Lewisham, National Parkinson Foundation Centre of Excellence and Regional Movement Disorders Unit, UK
&
K Ray Chaudhuri Research Nurse and Co-ordinator, University Hospital Lewisham, National Parkinson Foundation Centre of Excellence and Regional Movement Disorders Unit, UK; Consultant Neurologist and Co-Director, King’s College Hospital, National Parkinson Foundation Centre of Excellence and Regional Movement Disorders Unit, UK; King’s College, London, Guy’s, King’s & St Thomas’ School of Biomedical Medicine, UK; King’s College Hospital, Department of Neurology, 9th Floor Ruskin Wing, Denmark Hill, London, SE5 9RS, UK. [email protected]
Pages 111-118 | Published online: 05 Mar 2007

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

K Ray Chaudhuri. (2008) Crystallisation within transdermal rotigotine patch: is there cause for concern?. Expert Opinion on Drug Delivery 5:11, pages 1169-1171.
Read now
Dag Nyholm & Hans Lennernäs. (2008) Irregular gastrointestinal drug absorption in Parkinson's disease. Expert Opinion on Drug Metabolism & Toxicology 4:2, pages 193-203.
Read now
Mario Di Napoli, Imtiaz M Shah & David A Stewart. (2007) Molecular pathways and genetic aspects of Parkinson’s disease: from bench to bedside. Expert Review of Neurotherapeutics 7:12, pages 1693-1729.
Read now
Christopher Kenney & Joseph Jankovic. (2007) Rotigotine transdermal patch in the treatment of Parkinson’s disease and restless legs syndrome. Expert Opinion on Pharmacotherapy 8:9, pages 1329-1335.
Read now

Articles from other publishers (14)

WooJin Kim, Christine L. WattPaula EnrightLindsey SikoraJocelyn Zwicker. (2023) Management of Motor Symptoms for Patients with Advanced Parkinson's Disease without Safe Oral Access: A Scoping Review. Journal of Palliative Medicine 26:1, pages 131-141.
Crossref
Rashmi Trivedi, Milind Umekar, Nandkishore Kotagale, Smita Bonde & Jayshree Taksande. (2021) Design, evaluation and in vivo pharmacokinetic study of a cationic flexible liposomes for enhanced transdermal delivery of pramipexole. Journal of Drug Delivery Science and Technology 61, pages 102313.
Crossref
Antoniya Todorova & K. Ray Chaudhuri. 2016. Parkinson's Disease. Parkinson's Disease 48 62 .
. 2016. Parkinson's Disease. Parkinson's Disease 1 92 .
Kazuo Abe, Masashi Fujita & Hiroo Yoshikawa. (2015) Safety and Efficacy of a Transdermal Rotigotine for the Treatment of Fatigue and Quality of Life in Patients with Parkinson’s Disease. Advances in Parkinson's Disease 04:04, pages 79-83.
Crossref
Dhaval R. Kalaria, Pratikkumar Patel, Virginia Merino, Vandana B. Patravale & Yogeshvar N. Kalia. (2014) Controlled iontophoretic delivery of pramipexole: Electrotransport kinetics in vitro and in vivo. European Journal of Pharmaceutics and Biopharmaceutics 88:1, pages 56-63.
Crossref
Weidong Le, Pavani Sayana & Joseph Jankovic. (2013) Animal Models of Parkinson’s Disease: A Gateway to Therapeutics?. Neurotherapeutics 11:1, pages 92-110.
Crossref
Nikos Gorgoraptis, Yee-Haur Mah, Bjoern Machner, Victoria Singh-Curry, Paresh Malhotra, Maria Hadji-Michael, David Cohen, Robert Simister, Ajoy Nair, Elena Kulinskaya, Nick Ward, Richard Greenwood & Masud Husain. (2012) The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke. Brain 135:8, pages 2478-2491.
Crossref
Bettina Knie, M. Tanya Mitra, Kartik Logishetty & K. Ray Chaudhuri. (2011) Excessive Daytime Sleepiness in Patients with Parkinson?s Disease. CNS Drugs 25:3, pages 203-212.
Crossref
Wolfgang H. Oertel, Heike Benes, Diego Garcia-Borreguero, Peter Geisler, Birgit Högl, Claudia Trenkwalder, Ingrid Tacken, Erwin Schollmayer, Ralf Kohnen & Karin Stiasny-Kolster. (2008) One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome. Sleep Medicine 9:8, pages 865-873.
Crossref
M.A. De Souza Silva, B. Topic, J.P. Huston & C. Mattern. (2007) Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field. Synapse 62:3, pages 176-184.
Crossref
Lauren C. Seeberger & Robert A. Hauser. (2007) Optimizing bioavailability in the treatment of Parkinson's disease. Neuropharmacology 53:7, pages 791-800.
Crossref
Claudine M Baldwin & Gillian M Keating. (2007) Rotigotine Transdermal Patch. CNS Drugs 21:12, pages 1039-1055.
Crossref
Shridhar Hegde & Michelle Schmidt. 2007. Annual Reports in Medicinal Chemistry Volume 42. Annual Reports in Medicinal Chemistry Volume 42 505 554 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.